Hester Biosciences net profit rises 8 percent at Rs 13 crore in Q3

The company''s developmental activities are ongoing for the human COVID-19 vaccine with IIT Guwahati, it added.

Published On 2021-02-01 04:30 GMT   |   Update On 2021-02-01 04:30 GMT

New Delhi: Leading animal healthcare firm Hester Biosciences on Saturday reported a 7.7 per cent rise in its consolidated net profit to Rs 12.86 crore for the quarter ended December 31, 2020.

The company had posted a profit of Rs 11.94 crore for the corresponding period of the previous fiscal, Hester Biosciences said in a filing to the BSE.

Consolidated net sales of the company stood at Rs 56.89 crore for the quarter under consideration. It was Rs 50.69 crore for the same period a year ago, it added.

The company''s board has also approved, "issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 200 crore...," the filing said.

The company''s developmental activities are ongoing for the human COVID-19 vaccine with IIT Guwahati, it added.

The company is evaluating expansion opportunities in manufacturing and distribution of animal health products and biologicals, worldwide, Hester Biosciences said.

The company is also set to launch a new range of herbal health products in the current quarter, it added.



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News